Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Completed 9Unknown 3Terminated 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Melanoma 4Neuroblastoma 3Uterine Cervical Neoplasms 2Nasopharyngeal Carcinoma 2Lymphoma, Non-Hodgkin 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Stomach Neoplasms 1Solid Tumors 1Solid Tumor 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Head and Neck Neoplasms 1Carcinoma, Renal Cell 1Carcinoma 1Anus Neoplasms 1Advanced Refractory Solid Tumors 1Advanced Malignant Solid Tumor 1

Interventions

Cyclophosphamide 12Vincristine 10Radiotherapy 10Carboplatin 10Cisplatin 8Melphalan 7Etoposide 73-Iodobenzylguanidine 7Isotretinoin 6Filgrastim 6Doxorubicin 6aldesleukin 4Peripheral Blood Stem Cell Transplantation 4Busulfan 4etoposide phosphate 3Topotecan 3Neoadjuvant Therapy 3Interleukin-2 3Ifosfamide 3fludarabine 2dinutuximab 2Vindesine 2Polymerase Chain Reaction 2Granulocyte-Macrophage Colony-Stimulating Factor 2Dacarbazine 2Chemotherapy, Adjuvant 2sargramostim 1irinotecan sucrosofate 1ganglioside, GD2 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Neuroblastoma × Interleukin-2 × Clear all
NCT01701479 2020-07-14

LTI

St. Anna Kinderkrebsforschung

Phase 1/2 Unknown
288 enrolled
CNS

Neuroblastoma

NCT02173093 2019-01-29

Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma

University of Virginia

Phase 1/2 Unknown
40 enrolled
CNS

Neuroblastoma

NCT02771743 2016-05-24

Response-based Treatment of High-risk Neuroblastoma

Samsung Medical Center

Phase 2 Unknown
54 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡